The chemical composition of LOEO, including carvacrol, thymol, and γ-gurjunene, along with its potent acetylcholinesterase (AChE)-inhibitory activity, positions LOEO as a valuable candidate for therapies targeting neurodegenerative diseases, particularly Alzheimer’s disease. The gene discussed is ACHE; the disease is neurodegenerative disease.